Showing results 1 to 2 of 2
Title | Author(s) | Issue Date | |
---|---|---|---|
Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination Journal:Molecular Therapy - Oncolytics | 2020 | ||
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment Journal:Molecular Therapy - Oncolytics | 2021 |